DEPOCYT vs TOLAK

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. DEPOCYT and TOLAK are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPOCYT	TOLAK
Rating	70/100	72/100
Pharmacy pays	—	$0.61 /mL
Type	RX	RX
Active ingredient	CYTARABINE	FLUOROURACIL
Manufacturer	Pacira Pharms Inc	Hill Dermaceuticals
Dosage forms	Injectable, Liposomal	Topical
Drug class	Nucleoside Metabolic Inhibitor	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Leukemia, Lymphoma, Meningeal Neoplasms	Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

depocyt tolak

Rating

70/100

72/100

Pharmacy pays

—

$0.61 /mL

Type

Active ingredient

CYTARABINE

FLUOROURACIL

Manufacturer

Pacira Pharms Inc

Hill Dermaceuticals

Dosage forms

Injectable, Liposomal

Topical

Drug class

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Leukemia, Lymphoma, Meningeal Neoplasms

Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

Frequently asked questions

Which is better-rated, Depocyt or Tolak?

By our independent rating, Tolak scores higher — 3.6 vs 3.5 out of 5 for Depocyt. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depocyt and Tolak?

Depocyt contains Cytarabine, while Tolak contains Fluorouracil — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.